Guanethidine blocks the 2-deoxy-d-glucose-induced hypothalamic noradrenergic drive to hyperglycemia

This publication has 15 references indexed in Scilit:

• Relationships between brain noradrenergic activity and blood glucose
  Nature, 1984
• Serotoninergic Control of Growth Hormone Secretion: Hypothalamic Dopamine, Norepinephrine, and Serotonin Levels and Metabolism in Three Hyposomatotropic Rat Models and in Normal Rats*
  Endocrinology, 1982
• Central nervous system regulation of liver and adipose tissue metabolism
  Diabetologia, 1981
• Changes of insulinemia, glycemia and feeding behavior induced by VMH-procainization in the rat
  Brain Research, 1979
• Selectivity of neuronal degeneration produced by chronic guanethidine treatment
  Journal of Neurocytology, 1977
• Effect of 2–Deoxy—D—Glucose on Insulin Response to Glucose in Intact and Adrenalectomized Monkeys
  Endocrinology, 1973
• Central Nervous System Mediated Inhibition of Insulin Secretion Due to 2-Deoxyglucose
  Hormone and Metabolic Research, 1973
• A central site for the hyperglycemic action of 2-deoxy-D-glucose in mouse and rat
  Life Sciences, 1971
• Reciprocal Influences of the Ventromedial and Lateral Hypothalamic Nuclei on Blood Glucose Level and Liver Glycogen Content
  Nature, 1966
• A study of gluconeogenesis by the administration of 2-deoxyglucose. I
  Metabolism, 1966